Literature DB >> 31062228

Should Evidence Come with an Expiration Date?

Palmer Greene1,2, Vinay Prasad3, Adam Cifu4.   

Abstract

Mesh：

Year:  2019        PMID： 31062228      PMCID： PMC6614217          DOI： 10.1007/s11606-019-05032-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  7 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

2.  Estimation of Overdiagnosis of Lung Cancer in Low-Dose Computed Tomography Screening: A Secondary Analysis of the Danish Lung Cancer Screening Trial.

Authors:  Bruno Heleno; Volkert Siersma; John Brodersen
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

3.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Authors:  Eugene Braunwald; Michael J Domanski; Sarah E Fowler; Nancy L Geller; Bernard J Gersh; Judith Hsia; Marc A Pfeffer; Madeline M Rice; Yves D Rosenberg; Jean L Rouleau
Journal:  N Engl J Med       Date:  2004-11-07       Impact factor: 91.245

4.  Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials.

Authors:  P S Sanmuganathan; P Ghahramani; P R Jackson; E J Wallis; L E Ramsay
Journal:  Heart       Date:  2001-03       Impact factor: 5.994

5.  Final report on the aspirin component of the ongoing Physicians' Health Study.

Authors: 
Journal:  N Engl J Med       Date:  1989-07-20       Impact factor: 91.245

6.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

7.  Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial.

Authors:  J Michael Gaziano; Carlos Brotons; Rosa Coppolecchia; Claudio Cricelli; Harald Darius; Philip B Gorelick; George Howard; Thomas A Pearson; Peter M Rothwell; Luis Miguel Ruilope; Michal Tendera; Gianni Tognoni
Journal:  Lancet       Date:  2018-08-26       Impact factor: 79.321
  7 in total
  1 in total

1.  Recommendation Reversals in Gastroenterology Clinical Practice Guidelines.

Authors:  Reza Gholami; Rishad Khan; Anushka Ramkissoon; Abdulrahman Alabdulqader; Nikko Gimpaya; Rishi Bansal; Michael A Scaffidi; Vinay Prasad; Allan S Detsky; Jeffrey P Baker; Samir C Grover
Journal:  J Can Assoc Gastroenterol       Date:  2021-10-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.